Search

Author/Creator Li, Zhi‐Yu

1. Drug resistance associates with activation of Nrf2 in MCF‐7/DOX cells, and wogonin reverses it by down‐regulating Nrf2‐mediated cellular defense response. Issue 10 (16th May 2012)

Authors:
Zhong, Yan; Zhang, Fengyi; Sun, Zhongying; Zhou, Wei; Li, Zhi‐Yu; You, Qi‐Dong; Guo, Qing‐Long; Hu, Rong
Journal:
Molecular carcinogenesis
Issue:
Volume 52:Issue 10(2013:Oct.)
Page Start:
824
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Drug resistance associates with activation of Nrf2 in MCF‐7/DOX cells, and wogonin reverses it by down‐regulating Nrf2‐mediated cellular defense response. Issue 10 (16th May 2012)

Authors:
Zhong, Yan; Zhang, Fengyi; Sun, Zhongying; Zhou, Wei; Li, Zhi‐Yu; You, Qi‐Dong; Guo, Qing‐Long; Hu, Rong
Journal:
Molecular carcinogenesis
Issue:
Volume 52:Issue 10(2013:Oct.)
Page Start:
824
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. LW106, a novel indoleamine 2, 3‐dioxygenase 1 inhibitor, suppresses tumour progression by limiting stroma‐immune crosstalk and cancer stem cell enrichment in tumour micro‐environment. (3rd June 2018)

Authors:
Fu, Rong; Zhang, Yi‐Wei; Li, Hong‐Mei; Lv, Wen‐Cong; Zhao, Li; Guo, Qing‐Long; Lu, Tao; Weiss, Stephen J; Li, Zhi‐Yu; Wu, Zhao‐Qiu
Journal:
British journal of pharmacology
Issue:
Volume 175:Number 14(2018)
Page Start:
3034
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗